Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Melanoma 5Colorectal Neoplasms 3Thyroid Neoplasms 2Ovarian Neoplasms 2Glioma 2Endometrial Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Stomach Neoplasms 1Solid Tumor 1Rectal Neoplasms 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Neurofibromatosis 1 1Neoplasm Metastasis 1Multiple Myeloma 1Lymphoma 1Lymphatic Metastasis 1Lung Neoplasms 1Leukemia, Hairy Cell 1Hereditary Sensory and Autonomic Neuropathies 1Hematologic Neoplasms 1Fallopian Tube Neoplasms 1Esophageal Neoplasms 1Colonic Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Hepatocellular 1Breast Neoplasms 1

Interventions

pembrolizumab 19Specimen Handling 19Biopsy 13Magnetic Resonance Spectroscopy 12Carboplatin 11Paclitaxel 10Pemetrexed 8Nivolumab 7Irinotecan 7Gemcitabine 7trastuzumab deruxtecan 6Fulvestrant 6Radiosurgery 5Leucovorin 5Fluorouracil 5Cisplatin 5Cetuximab 5Bevacizumab 5palbociclib 4durvalumab 4Taxes 4Oxaliplatin 4Letrozole 4Docetaxel 4ribociclib 3olaparib 3Trastuzumab 3Panitumumab 3Midazolam 3Ipilimumab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasm Metastasis × binimetinib × 30 days × Clear all
NCT05564377 2026-06-12

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

National Cancer Institute (NCI)

Phase 2 Recruiting
2,900 enrolled
Gynecologic

Fallopian Tube Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡